Literature DB >> 30843005

Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta.

Leila S Arani1, Mohammad H Gharavi, Mahdi Z Zadeh, William Y Raynor, Siavash M Seraj, Caius M Constantinescu, Oke Gerke, Thomas J Werner, Poul F Høilund-Carlsen, Abass Alavi.   

Abstract

OBJECTIVE: We aimed to assess the feasibility of quantifying fluorine-18-fluorodexoglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) uptake in abdominal aorta and examine their association with age and cardiovascular risk factors. SUBJECTS AND METHODS: Our study comprised 123 subjects (48±14 years of age, 62 men) including 78 healthy volunteers and 45 patients with chest pain syndrome, who originally enrolled in the CAMONA study in Odense, Denmark (NCT01724749). All subjects underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) and 18F-NaF PET/CT on separate days, 180min and 90min after administration of tracers, respectively. The global tracer uptake value (GTUV) in the abdominal aorta was determined as sum of the product of each slice area and its corresponding average standardized uptake value (SUV mean), divided by the sum of those slice areas. In addition, for each subject, the 10 years Framingham risk score (FRS) was calculated. The correlations between 18F-NaF and 18F-FDG GTUV with age and 10 years FRS were assessed in all, healthy and patient subjects.
RESULTS: There was a significant, positive correlation between subjects' age and 18F-NaF GTUV (r=0.35, P<0.001), but not 18F-FDG GTUV (r=0.06, P=0.53). Also, there was a significant, positive correlation between 10 years FRS and 18F-NaF GTUV (r=0.30, P<0.001), but not 18F-FDG GTUV (r=0.01, P=0.95). Individual differences in 18F-FDG and 118F-NaF uptake were large in both healthy subjects and patients.
CONCLUSION: In this study, the global uptake of 18F-NaF in abdominal aorta was positively associated with age and 10 years FRS in all subjects, healthy and patient groups, whereas the global uptake of 18F-FDG was not.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30843005     DOI: 10.1967/s002449910954

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  9 in total

Review 1.  "Vascular inflammation and cardiovascular disease: review about the role of PET imaging".

Authors:  Antonio Maria Sammartino; Raffaele Falco; Andrea Drera; Francesco Dondi; Pietro Bellini; Francesco Bertagna; Enrico Vizzardi
Journal:  Int J Cardiovasc Imaging       Date:  2022-10-18       Impact factor: 2.316

2.  Role of 18F-NaF-PET in assessing aortic valve calcification with age.

Authors:  Chaitanya Rojulpote; Austin J Borja; Vincent Zhang; Mahmoud Aly; Benjamin Koa; Siavash M Seraj; William Y Raynor; Esha Kothekar; Fatemeh Kaghazchi; Thomas J Werner; Oke Gerke; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

3.  Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects.

Authors:  Vincent Zhang; Austin J Borja; Chaitanya Rojulpote; Sayuri Padmanabhan; Shivaraj Patil; Karthik Gonuguntla; Mona-Elisabeth Revheim; Thomas J Werner; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

4.  18F-sodium fluoride: An emerging tracer to assess active vascular microcalcification.

Authors:  William Y Raynor; Austin J Borja; Chaitanya Rojulpote; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  J Nucl Cardiol       Date:  2020-05-10       Impact factor: 5.952

5.  The Usefulness of [18F]F-Fluorodeoxyglucose and [18F]F-Sodium Fluoride Positron Emission Tomography Imaging in the Assessment of Early-Stage Aortic Valve Degeneration after Transcatheter Aortic Valve Implantation (TAVI)-Protocol Description and Preliminary Results.

Authors:  Danuta Sorysz; Rafał Januszek; Anna Sowa-Staszczak; Anna Grochowska; Marta Opalińska; Maciej Bagieński; Barbara Zawiślak; Artur Dziewierz; Tomasz Tokarek; Agata Krawczyk-Ożóg; Stanisław Bartuś; Dariusz Dudek
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

6.  Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT.

Authors:  Leila S Arani; Mahdi Zirakchian Zadeh; Babak Saboury; Mona-Elisabeth Revheim; Brian Øestergaard; Austin J Borja; Davoud Samadi Samarin; Siavash Mehdizadeh Seraj; Eman Kalbush; Cyrus Ayubcha; Michael A Morris; Tom J Werner; Niels Abildgaard; Poul F Høilund-Carlsen; Abass Alavi
Journal:  J Nucl Cardiol       Date:  2021-01-03       Impact factor: 5.952

Review 7.  Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder.

Authors:  Michael Mayer; Austin J Borja; Emily C Hancin; Thomas Auslander; Mona-Elisabeth Revheim; Mateen C Moghbel; Thomas J Werner; Abass Alavi; Chamith S Rajapakse
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

Review 8.  Atherosclerosis Imaging with 18F-Sodium Fluoride PET.

Authors:  Poul F Høilund-Carlsen; Reza Piri; Caius Constantinescu; Kasper Karmark Iversen; Thomas J Werner; Michael Sturek; Abass Alavi; Oke Gerke
Journal:  Diagnostics (Basel)       Date:  2020-10-20

Review 9.  PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders.

Authors:  William Y Raynor; Peter Sang Uk Park; Austin J Borja; Yusha Sun; Thomas J Werner; Sze Jia Ng; Hui Chong Lau; Poul Flemming Høilund-Carlsen; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.